GeoVax Labs (GOVXW) Stock Analysis

What GeoVax Labs does

GeoVax Labs, Inc. is a clinical-stage biotechnology firm dedicated to creating human vaccines and immunotherapies. The company's core mission involves tackling a range of infectious diseases and various solid tumor cancers. Their innovative approach is centered on a proprietary modified vaccinia ankara virus-like particle (MVA-VLP) vaccine platform. The company's pipeline includes diverse preventive vaccine candidates aimed at combating critical pathogens such as COVID-19, human immunodeficiency virus (HIV), Zika virus, malaria, and hemorrhagic fever viruses like Ebola, Sudan, Marburg, and Lassa. In parallel, GeoVax is advancing therapeutic vaccines designed to address existing conditions, including HIV, chronic Hepatitis B infections, and solid tumor malignancies. Key programs include GEO-CM04S1, a COVID-19 preventive vaccine candidate currently in Phase 2 clinical trials, and Gedeptin, a novel, patented product in Phase 1/2 clinical trials for treating advanced head and neck squamous cell carcinoma, which is also being explored for broader solid tumor applications. Additionally, the company is developing GEO-CM02, a pan-coronavirus vaccine. The preclinical stage features several other promising candidates, such as GEO-ZM02 for Zika, GEO-MM02 for malaria, GEO-EM01 for fever viruses (Ebola, Sudan, and Marburg), and GEO-LM01 targeting Lassa fever. GeoVax maintains strategic collaborations and partnership agreements with prominent institutions, including the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health, the U.S. Department of Defense, Emory University, and the Burnet Institute. Established in 1988, GeoVax Labs, Inc. operates from its headquarters in Smyrna, Georgia.

Key metrics

ETFs linked to GOVXW

Broad-market and Healthcare sector ETFs an investor holding GeoVax Labs is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how GOVXW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for GeoVax Labs?

GeoVax Labs trades under the ticker GOVXW on NASDAQ.

Which exchange is GOVXW listed on?

GOVXW is listed on NASDAQ.

What sector does GeoVax Labs operate in?

GeoVax Labs is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze GOVXW in a portfolio?

PortView shows GOVXW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.